Surgical Endoscopy and Gastrointestinal Motility Unit, Department of Surgery, Medical Research Institute, Alexandria University, 165 Horreya Avenue, Hadara, Alexandria, 21561, Egypt.
Department of Surgery, Faculty of Medicine, Alexandria University, Alexandria, Egypt.
Obes Surg. 2021 May;31(5):2050-2061. doi: 10.1007/s11695-020-05211-x. Epub 2021 Jan 6.
Surgical therapy for post-bariatric surgery complications is associated with significant morbidity and mortality. Endoscopic options like primarily endoscopically placed fully covered self-expandable metallic stents (SEMS) offer significant benefits for the management of leaks and obstructions or stenosis, and even in case of mega stent failure, further endoscopic techniques could resolve the situation.
We conducted a single-centre retrospective study on patients with leakage and stenosis/obstruction after bariatric surgery who were managed primarily by SEMS between January 2015 and January 2019. Clinical success rate was evaluated in terms of the cure of the reason for stenting, the need for other interventions, and the presentation of stent-related complications.
There were 58 patients included, (50 with leak, 8 with stenosis/obstruction following bariatric surgery). Mean time to stent placement was 6.82 (±1.64) days for the leak group and 35 (±21.13) days for the stenosis group (p = 0.019). Successful outcomes with SEMS alone were achieved in 42 (72.41%) patients, while 16 patients had failed SEMS treatment, of whom 14 were successfully managed by endoscopic procedures while two cases needed surgical intervention. Of the SEMS-related complications encountered, 25.86% were ulcers; 24.13%, vomiting; 22.41%, gastroesophageal reflux disease (GerdQ≥8); 18.96%, stent migration; and 5.17%, stent intolerance.
A mega stent is an effective and safe tool for the early management of post-bariatric surgery leakage and stenosis, and it is associated with acceptable rates of failure that can be managed by further endoscopic techniques in most of the patients.
减重手术后并发症的手术治疗与显著的发病率和死亡率相关。内镜治疗选择,如主要经内镜放置的全覆膜自膨式金属支架(SEMS),为处理漏口和梗阻/狭窄提供了显著的益处,甚至在巨型支架失败的情况下,进一步的内镜技术也可以解决问题。
我们对 2015 年 1 月至 2019 年 1 月期间主要通过 SEMS 治疗的减重手术后漏口和狭窄/梗阻患者进行了单中心回顾性研究。通过支架置入的原因治愈、其他干预措施的需求以及支架相关并发症的发生情况来评估临床成功率。
共纳入 58 例患者,(50 例漏口,8 例减重手术后狭窄/梗阻)。漏口组支架置入时间的平均值为 6.82(±1.64)天,狭窄组为 35(±21.13)天(p=0.019)。42 例(72.41%)患者单独使用 SEMS 获得了成功的结果,而 16 例患者 SEMS 治疗失败,其中 14 例通过内镜手术成功管理,2 例需要手术干预。在遇到的与 SEMS 相关的并发症中,25.86%为溃疡;24.13%,呕吐;22.41%,胃食管反流病(GerdQ≥8);18.96%,支架迁移;和 5.17%,支架不耐受。
巨型支架是治疗减重手术后漏口和狭窄的有效且安全的工具,其失败率可以接受,大多数患者可以通过进一步的内镜技术来管理。